166 related articles for article (PubMed ID: 19830828)
21. Cardiac changes associated with growth hormone therapy among children treated with anthracyclines.
Lipshultz SE; Vlach SA; Lipsitz SR; Sallan SE; Schwartz ML; Colan SD
Pediatrics; 2005 Jun; 115(6):1613-22. PubMed ID: 15930224
[TBL] [Abstract][Full Text] [Related]
22. Influence of the polymorphism in candidate genes on late cardiac damage in patients treated due to acute leukemia in childhood.
Rajić V; Aplenc R; Debeljak M; Prestor VV; Karas-Kuzelicki N; Mlinaric-Rascan I; Jazbec J
Leuk Lymphoma; 2009 Oct; 50(10):1693-8. PubMed ID: 19863340
[TBL] [Abstract][Full Text] [Related]
23. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines.
Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I
J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994
[TBL] [Abstract][Full Text] [Related]
24. Echocardiographic surveillance for asymptomatic late-onset anthracycline cardiomyopathy in childhood cancer survivors.
Abosoudah I; Greenberg ML; Ness KK; Benson L; Nathan PC
Pediatr Blood Cancer; 2011 Sep; 57(3):467-72. PubMed ID: 21280201
[TBL] [Abstract][Full Text] [Related]
25. [Echocardiographic assessment of circulation system in patients during and 3-5 years after all therapy in childhood].
Ostański M; Sońta-Jakimczyk D
Wiad Lek; 2002; 55(3-4):164-73. PubMed ID: 12182001
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis of anthracycline-induced late cardiomyopathy by exercise-spiroergometry and stress-echocardiography.
Hauser M; Gibson BS; Wilson N
Eur J Pediatr; 2001 Oct; 160(10):607-10. PubMed ID: 11686505
[TBL] [Abstract][Full Text] [Related]
27. Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients.
Ganame J; Claus P; Uyttebroeck A; Renard M; D'hooge J; Bijnens B; Sutherland GR; Eyskens B; Mertens L
J Am Soc Echocardiogr; 2007 Dec; 20(12):1351-8. PubMed ID: 17604960
[TBL] [Abstract][Full Text] [Related]
28. Favourable outcome of patients with childhood acute promyelocytic leukaemia after treatment with reduced cumulative anthracycline doses.
Creutzig U; Zimmermann M; Dworzak M; Urban C; Henze G; Kremens B; Lakomek M; Bourquin JP; Stary J; Reinhardt D
Br J Haematol; 2010 May; 149(3):399-409. PubMed ID: 20230404
[TBL] [Abstract][Full Text] [Related]
29. [Evaluation of systolic and diastolic function of the left ventricle in children with acute lymphoblastic leukaemia before treatment].
Jackowska T; Pleskot M; Gołabek M; Rokicka-Milewska R; Wróblewska-Kałuzewska M; Wypych A; Matysiak M; Klus K; Juraszewska E; Balwierz W; Wójcik B; Sadurska E; Kowalczyk J; Stencel D; Siwinska A; Wachowiak J; Szmyd K; Kukawczyńska E; Chybicka A; Płoszyńska A; Aleszewicz-Baranowska J; Balcerska A; Ostański M; Pobudejska A; Sońta-Jakimczyk D; Krenke K; Madry W; Syczewska M; Rudziński A
Przegl Lek; 2004; 61 Suppl 2():70-5. PubMed ID: 15686051
[TBL] [Abstract][Full Text] [Related]
30. Ventricular systolic reserve in asymptomatic children previously treated with low doses of anthracyclines.
Guimaraes-Filho F; Tan D; Braga J; Rodrigues A; Waib P; Matsubara B
Am J Cardiol; 2007 Oct; 100(8):1303-6. PubMed ID: 17920375
[TBL] [Abstract][Full Text] [Related]
31. Early prediction of anthracycline induced cardiotoxicity.
Erkus B; Demirtas S; Yarpuzlu AA; Can M; Genc Y; Karaca L
Acta Paediatr; 2007 Apr; 96(4):506-9. PubMed ID: 17391467
[TBL] [Abstract][Full Text] [Related]
32. Noninvasive early detection of anthracycline-induced cardiotoxicity in patients with hematologic malignancies using the phased tracking method.
Saito Y; Susukida I; Uzuka Y; Kanai H
Cancer Med; 2016 Sep; 5(9):2276-85. PubMed ID: 27484957
[TBL] [Abstract][Full Text] [Related]
33. Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study.
Sorensen K; Levitt GA; Bull C; Dorup I; Sullivan ID
Cancer; 2003 Apr; 97(8):1991-8. PubMed ID: 12673729
[TBL] [Abstract][Full Text] [Related]
34. Acute and late toxicities of pirarubicin in the treatment of childhood acute lymphoblastic leukemia: results from a clinical trial by the Japan Association of Childhood Leukemia Study.
Hori H; Kudoh T; Nishimura S; Oda M; Yoshida M; Hara J; Tawa A; Usami I; Tanizawa A; Yumura-Yagi K; Kato K; Kobayashi R; Komada Y; Matsuo K; Horibe K;
Int J Clin Oncol; 2017 Apr; 22(2):387-396. PubMed ID: 27858183
[TBL] [Abstract][Full Text] [Related]
35. Myocardial 2D Strain During Long-Term (>5 Years) Follow-Up of Childhood Survivors of Acute Lymphoblastic Leukemia Treated With Anthracyclines.
Pourier MS; Mavinkurve-Groothuis AMC; Dull MM; Weijers G; Loonen J; Bellersen L; de Korte CL; Kapusta L
Am J Cardiol; 2020 Jul; 127():163-168. PubMed ID: 32444028
[TBL] [Abstract][Full Text] [Related]
36. Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer.
Lipshultz SE; Lipsitz SR; Mone SM; Goorin AM; Sallan SE; Sanders SP; Orav EJ; Gelber RD; Colan SD
N Engl J Med; 1995 Jun; 332(26):1738-43. PubMed ID: 7760889
[TBL] [Abstract][Full Text] [Related]
37. An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies.
Zerra P; Cochran TR; Franco VI; Lipshultz SE
Expert Opin Pharmacother; 2013 Aug; 14(11):1497-513. PubMed ID: 23705955
[TBL] [Abstract][Full Text] [Related]
38. [Echocardiography studies for detection of cardiotoxic side effects of anthracycline therapy in childhood].
Richter R; Grumpelt U; Mittler U; Kluba U
Monatsschr Kinderheilkd; 1990 Dec; 138(12):823-7. PubMed ID: 1965011
[TBL] [Abstract][Full Text] [Related]
39. Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes--a report from the Children's Oncology Group.
Blanco JG; Sun CL; Landier W; Chen L; Esparza-Duran D; Leisenring W; Mays A; Friedman DL; Ginsberg JP; Hudson MM; Neglia JP; Oeffinger KC; Ritchey AK; Villaluna D; Relling MV; Bhatia S
J Clin Oncol; 2012 May; 30(13):1415-21. PubMed ID: 22124095
[TBL] [Abstract][Full Text] [Related]
40. Exercise echocardiography in asymptomatic survivors of childhood cancer treated with anthracyclines: a prospective follow-up study.
Sieswerda E; Kremer LC; Vidmar S; De Bruin ML; Smibert E; Sjöberg G; Cheung MM; Weintraub RG
Pediatr Blood Cancer; 2010 Apr; 54(4):579-84. PubMed ID: 20014238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
